Better Money Decisions’s Biogen BIIB Stock Holding History

Better Money Decisions’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2	Closed	-$1K	–	122
2021 Q3	$1K	Sell	2 -3	-60%	-$983	﹤0.01%	617
2021 Q2	$2K	Hold	5	–	–	﹤0.01%	581
2021 Q1	$1K	Buy	+5	New	+$1.35K	﹤0.01%	556

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Better Money Decisions's BIIB Position: Q4 2021 in Review

Better Money Decisions sold out of Biogen (BIIB) in Q4 2021, closing a stake of 2 shares — an estimated $1K sold.

Better Money Decisions first reported a position in BIIB in Q1 2021 and held it in 3 quarters. The position peaked at $2K in Q2 2021. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

Better Money Decisions reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
Better Money Decisions sold 2 Biogen shares in Q4 2021, an estimated $1K.
Better Money Decisions first reported a position in Biogen in Q1 2021 and held it in 3 quarters.
Better Money Decisions's Biogen position peaked at $2K in Q2 2021.
1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Better Money Decisions's 13F filing for Q4 2021, filed 14 Feb 2022.